Blog - QualityStocks

WednesdayJul 01, 2026 3:27 pm

QualityStocksNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Targets Untapped Potential of Jameson Land Basin

Greenland Energy (NASDAQ: GLND) is advancing a significant opportunity in Greenland’s Jameson Land Basin, one of the world’s largest remaining underexplored onshore hydrocarbon regions spanning more than 8,400 square kilometers. Under an agreement with 80 Mile, Greenland Energy will fully fund a two-well drilling program planned for the second half of 2026, earning a 70% interest in the project while 80 Mile retains 30%. The basin has attracted decades of industry attention and substantial historical investment due to its potential resource scale. GLND has engaged Halliburton to provide consulting services, logistics planning, and operational support, while additional agreements with Stampede Drilling…

WednesdayJul 01, 2026 2:09 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Developing Solutions for an Era of Increasing GPS Interference

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is developing GPS-free navigation and target acquisition technology designed to operate in Denied, Degraded, Intermittent, and Limited (“DDIL”) environments, addressing a growing challenge highlighted in a recent article. The piece examines how GPS jamming has become increasingly common in modern warfare, disrupting navigation, communications, drone operations and precision targeting while also affecting civilian aviation, shipping and transportation networks. As reliance on GPS exposes both military and commercial systems to interference, SPARC AI’s software-only platform leverages artificial intelligence, advanced mathematics and edge…

WednesdayJul 01, 2026 12:00 pm

The Next Battle in Space Isn’t Launching Satellites. It’s Managing Them.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. SpaceX's record June 2026 IPO put a public spotlight on space, yet most of the sector's frontier companies remain private and out of reach for public investors Antaris, a software-defined space infrastructure company backed by Planet Ventures, signed a memorandum of agreement with Transcelestial to develop and flight-test a combined surveillance and optical-communications architecture on its JANUS-2 mission in late 2026 Planet Ventures gives public-market investors exposure to private space companies such as Antaris, Relativity Space, and General Astronautics that are typically accessible only…

WednesdayJul 01, 2026 11:15 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Santa Fe, Walker Lane amid Tightening Gold Supply Dynamics

Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Top gold-producing countries are showing strain of widespread government, cost and environmental pressures. These pressures strengthen the case for secure, transparent and infrastructure-supported gold development in the United States. Existing mine infrastructure, historical production, oxide material and location in a leading U.S. gold state may give Lahontan’s Santa Fe project a different development profile. Global gold supply is entering a more complicated era, shaped not only by geology and discovery rates but also by government policy, rising operating costs, safety enforcement, environmental oversight and growing…

WednesdayJul 01, 2026 10:40 am

Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals

Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical companies continuing to commit substantial capital to preclinical and early-stage innovation. The Jazz Pharmaceuticals–AbCellera collaboration illustrates how differentiated antibody technologies can command significant financial commitments before entering clinical development. VERAXA Biotech AG is positioning its technology platform across both ADCs and T-cell engagers, two therapeutic modalities that continue to attract strategic partnerships and acquisitions. Platform technologies and individual drug candidates both represent potential avenues for future partnering, licensing, and collaboration agreements. Recent transactions across the sector demonstrate that pharmaceutical companies are actively seeking access to…

WednesdayJul 01, 2026 10:30 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Delivers First Edge AI Intoxication Detection Kiosk Prototypes

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio kiosks use artificial intelligence and voice analysis to detect potential intoxication and fatigue in workplace environments. The company is targeting industries such as mining, aviation, construction, transportation, and law enforcement, where safety-sensitive operations require large-scale screening. MindBio’s AI models have been trained on more than 50 million data points and analyze over 140 acoustic markers associated with impairment. Prototype kiosks are entering testing, validation, and data-analysis phases, before broader commercial deployment. The company is positioning this important new technology as a faster and…

WednesdayJul 01, 2026 9:50 am

QualityStocksNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Increases Solana Treasury to 7.55 Million SOL

Forward Industries (NASDAQ: FWDI) announced that it acquired more than 500,000 SOL during its fiscal third quarter of 2026 at an average purchase price of approximately $79 per SOL, increasing its Solana treasury to 7.55 million SOL as of June 30, 2026. The company also said it sold 93,642 shares through its at-the-market offering during the quarter while achieving annualized SOL-per-share growth of 36%. Forward said its recent inclusion in the Russell 2000 and Russell 3000 indexes enhances its ability to raise capital when its shares trade at a premium to net asset value, complementing its strategy of using fwdSOL…

WednesdayJul 01, 2026 9:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma executive co-chairman and co-founder Anthony Durkacz appeared as a guest on the BioMedWire Podcast. Durkacz outlined the company’s strategy for advancing Lucid-MS, the company’s lead drug candidate for multiple sclerosis. The Quantum BioPharma exec also provided an update on unbuzzd, the company’s innovative, clinically validated alcohol metabolism accelerator designed to help sober people up faster. Executive thought leadership has become an increasingly important component of corporate communications, particularly in highly specialized industries such as biotechnology. Through podcasts, interviews and other educational forums,…

WednesdayJul 01, 2026 9:40 am

QualityStocksNewsBreaks – Suntex Enterprises Inc. (OTC: SNTX) Highlights Second-Quarter Operational Progress

Suntex Enterprises (OTC: SNTX) reported what management described as a defining second quarter, highlighting progress in executing its long-term growth strategy through expansion of its operating platform, advancement of its approximately 100-acre South Texas mixed-use development, growth across its seven wholly owned subsidiaries and continued strengthening of its leadership team and corporate governance. The company said its operating momentum accelerated late in the quarter as subsidiary JA Development & Construction was selected as general contractor for the approximately $4 million Social Padel Club development in Austin, Texas, while subsidiary Deep South Electrical Contractors secured approximately $1.41 million in commercial electrical…

WednesdayJul 01, 2026 9:30 am

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Announces Term Sheet for CAD$5 Million Private Placement

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced it has executed a term sheet with arm's-length institutional investors for a previously announced non-brokered private placement with a notional subscription amount of approximately CAD$5 million. The offering will consist of 6,764,070 units at a notional price of CAD$0.7392 per unit, with each unit comprising one common share and one common share purchase warrant, and is expected to close on or about July 15, 2026, subject to customary conditions and regulatory approvals. The company said proceeds from the…

Site Search

Company Search